The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...

The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...

Demand GLP-1 Medications as Prescription Drug Market GrowsSchaumburg, Illinois, Feb 21, 2025 - (ACN Newswire) - Giftify, Inc.

Giftify (GIFT) announced that CardCash.com is offering consumers smart saving solutions for high-cost GLP-1 weight loss prescription ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Eli Lilly has launched a new website-based access programme for some drugs like its new obesity therapy Zepbound ... it easier for patients to access its discount and savings schemes.

President Trump is going scorched earth on America’s major European trading partners. Vowing to impose reciprocal tariffs on ...

These super high-flying US stocks have soared 222%, 122%, and 150%, respectively, in 2025. Let's take a look why.